ArticleThe New England journal of medicine2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,547 papers cite itlatest 60 shown
this paperpooled ittrialcites it